Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila-Reference-Cited by-同舟云学术

Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila

Published:2023-09 Issue: Volume:185 Page:106236
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Campesan Susanna,del Popolo Ivana,Marcou Kyriaki,Straatman-Iwanowska Anna,Repici Mariaelena,Boytcheva Kalina V.,Cotton Victoria E.,Allcock Natalie,Rosato Ezio,Kyriacou Charalambos P.,Giorgini Flaviano

Publisher

Elsevier BV

Subject

Neurology

Reference104 articles.

1. Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington’s disease;Andreassen;Ann. Neurol.,2001

2. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease;Antonini;Brain,1996

3. Weight loss in Huntington disease increases with higher CAG repeat number;Aziz;Neurology,2008

4. Neuronal expression of a single-subunit yeast NADH–ubiquinone oxidoreductase (Ndi1) extends Drosophila lifespan;Bahadorani;Aging Cell,2010

5. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat;Brouillet;J. Neurochem.,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases;Reviews in the Neurosciences;2024-08-20

2. Neuronal progenitors suffer genotoxic stress in theDrosophilaclock mutantper⁰;2024-08-16

3. Polyglutamine disorders: Pathogenesis and potential drug interventions;Life Sciences;2024-05